As of 2024-12-15, the Intrinsic Value of ALX Oncology Holdings Inc (ALXO) is
-14.33 USD. This ALXO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.45 USD, the upside of ALX Oncology Holdings Inc is
-1,088.32%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-14.33 USD
Intrinsic Value
ALXO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-14.33 - -14.33 |
-14.33 |
-1,088.32% |
| P/E |
(78.99) - (81.28) |
(77.10) |
-5417.1% |
| DDM - Stable |
(22.08) - (56.55) |
(39.32) |
-2811.6% |
| DDM - Multi |
(21.75) - (43.33) |
(28.96) |
-2097.5% |
ALXO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
76.47 |
| Beta |
2.35 |
| Outstanding shares (mil) |
52.74 |
| Enterprise Value (mil) |
73.10 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.82% |
| Cost of Debt |
5.00% |
| WACC |
10.04% |